M promotes tumor growth by differentiating into tolerogenic dendritic cells that produce interleukin-10 (32), and circulating M are recruited to primary tumors and metastatic sites, where they differentiate into M2 phenotype tumor-associated macrophages under the influence of chemokines, leading to immune suppression (33). Here, IL10 is linked to neoplasm.